四环医药:渼颜空间自主研发的童颜针获得国家药监局上市批准

格隆汇
27 Apr

格隆汇4月27日丨四环医药(00460.HK)宣布,集团旗下渼颜空间生物科技(吉林)有限公司自主研发的聚乳酸面部填充剂正式获得中国国家药品监督管理局批准的第三类医疗器械注册证,用以纠正中重度鼻唇沟皱纹。标志着四环医药在再生医美领域的又一重大突破,进一步巩固了集团在高端医美材料市场的技术领先地位。聚乳酸面部填充剂,市场简称“童颜针”,以左旋聚乳酸(PLLA)微球为核心成分,具有稳定的生物降解特性,可...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10